1-(5-isoquinolinesulfonyl)-2-methylpiperazine and cromakalim

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with cromakalim in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ito, K; Nishimura, K; Ota, M1
Gok, S; Gurpinar, T1

Other Studies

2 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and cromakalim

ArticleYear
Existence of two components in the tonic contraction of rat aorta mediated by alpha 1-adrenoceptor activation.
    British journal of pharmacology, 1991, Volume: 102, Issue:1

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Benzopyrans; Calcium; Calcium Channel Blockers; Calcium Radioisotopes; Carbamates; Cromakalim; In Vitro Techniques; Isoquinolines; Lanthanum; Male; Muscle Contraction; Muscle Tonus; Muscle, Smooth, Vascular; Nifedipine; Phenylcarbamates; Phenylephrine; Phosphatidylinositols; Piperazines; Protease Inhibitors; Pyrroles; Rats

1991
Vasodilator effects of cromakalim and HA 1077 in diabetic rat aorta.
    Swiss medical weekly, 2012, Volume: 142

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Aorta; Cromakalim; Diabetes Mellitus; In Vitro Techniques; KATP Channels; Male; Muscle, Smooth, Vascular; Rats; Rats, Wistar; rho-Associated Kinases; Signal Transduction; Streptozocin; Vasodilation; Vasodilator Agents

2012